Dare Bioscience (DARE) Shares Outstanding (2013 - 2026)
Dare Bioscience's (DARE) quarterly Shares Outstanding (Entity) came in at $11.2 million in Q4 2025, up 28.49% YoY from $8.7 million in Q4 2024, and down 19.75% on a QoQ basis from $13.9 million in Q3 2025.
Dare Bioscience (DARE) Shares Outstanding (2013 - 2026) Analysis & Trends
Dare Bioscience (DARE) has 13 years of Shares Outstanding (Entity) data on file, last reported at $11.2 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 28.49% year-over-year to $11.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $11.2 million (up 28.49% YoY) and the FY2025 annual result came in at $11.2 million, up 28.49% from the prior year.
- Shares Outstanding (Entity) slipped to $11.2 million in Q4 2025, from $13.9 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $13.9 million in Q3 2025 to a low of $3.9 million in Q1 2021.
- A 5-year average of $7.8 million and a median of $7.7 million in 2023 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Entity) surged 127.96% — and 2023, when it climbed 2.14%.
- Tracing DARE's Shares Outstanding (Entity) over 5 years: stood at $5.1 million in 2021, then soared by 38.71% to $7.1 million in 2022, then advanced by 17.86% to $8.3 million in 2023, then climbed by 4.44% to $8.7 million in 2024, then climbed by 28.49% to $11.2 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $11.2 million (Q4 2025), $13.9 million (Q3 2025), and $9.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Dare Bioscience | 12.36 Mn | -256,055.23 | -132,343.00 | 14.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 14.89 Mn |
| Dec 31, 2025 | 11.18 Mn |
| Sep 30, 2025 | 12.76 Mn |
| Jun 30, 2025 | 8.87 Mn |
| Mar 31, 2025 | 8.76 Mn |
| Dec 31, 2024 | 8.50 Mn |
| Sep 30, 2024 | 8.53 Mn |
| Jun 30, 2024 | 8.41 Mn |
| Mar 31, 2024 | 8.38 Mn |
| Dec 31, 2023 | 7.28 Mn |
| Sep 30, 2023 | 7.59 Mn |
| Jun 30, 2023 | 7.20 Mn |
| Mar 31, 2023 | 7.13 Mn |
| Dec 31, 2022 | 7.05 Mn |
| Sep 30, 2022 | 7.07 Mn |
| Jun 30, 2022 | 7.06 Mn |
| Mar 31, 2022 | 7.00 Mn |
| Dec 31, 2021 | 5.10 Mn |
| Sep 30, 2021 | 5.90 Mn |
| Jun 30, 2021 | 4.20 Mn |